cotta Acquires Online Aesthetic Medical Service MedMarge – M&A Online

News Highlights

cotta has made MedMarge, an online aesthetic medical service provider, a subsidiary. This M&A suggests the value of considering third-party succession as an alternative to closure or廃業 (going out of business) for medical institutions facing succession issues. It is important for chairpersons and directors to prepare with a 5-10 year timeframe starting around age 60 and to utilize specialized advisors focused on the medical industry.

M&A Medical Editorial Department’s Perspective

cotta’s acquisition of MedMarge is not merely an entry into the medical field by a company from a different industry. It is an investment in the growing field of online aesthetic medicine and should be viewed in the context of “business succession” that many medical institutions supported by M&A Medical (CentralMedience Inc.) face. Specifically, it suggests a path for clinics with a lack of successors to continue and develop their business through third-party succession, rather than choosing closure or 廃業. Collaboration with online platforms like MedMarge holds the potential for new value creation, such as addressing patient acquisition challenges faced by existing clinics, strengthening outreach to younger demographics, and even expanding into telemedicine. This case highlights the importance for chairpersons and directors, starting around age 60, to formulate business succession plans over a 5-10 year period and to seek out successors who can leverage their clinic’s strengths early on, in collaboration with specialized advisors experienced in medical M&A.

Points Raised by This News

• cotta’s acquisition of MedMarge represents a move by a company from a different industry to enter the growing online aesthetic medicine sector through M&A.
• It demonstrates that third-party succession is a viable option for clinics lacking successors, as an alternative to closure or business cessation.
• Collaboration with online platforms has the potential to create new value for existing clinics, such as strengthening patient acquisition and enabling telemedicine expansion.
• It suggests the importance of early business succession planning starting around age 60 and collaboration with specialists in medical M&A.

Practical Questions Arising from This News

• What specific aspects of MedMarge’s online aesthetic medical services attracted cotta’s interest?
• What synergistic effects does MedMarge expect from being acquired by cotta?
• How can this scheme serve as a reference for clinics lacking successors considering third-party succession?

If You Feel “Should I Consult Too?”

Are you struggling with succession issues at your clinic? As exemplified by the case of cotta and MedMarge, business succession is not merely an act of “handing over” to someone else; it can be an opportunity to leverage your clinic’s strengths and create new growth prospects. Before considering closure or 廃業, why not consult with specialists to objectively evaluate your clinic’s business value and find the optimal successor? Early consultation increases the likelihood of a more favorable succession arrangement.

M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics with a complete success fee basis. Consultations are handled with strict confidentiality. Free consultations here